| 000 | 01736 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516020507.0 | ||
| 264 | 0 | _c20110516 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2010.11.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeoh, Deanna | |
| 245 | 0 | 0 |
_aDasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cApr 2011 |
||
| 300 |
_a187-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDasatinib |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins pp60(c-src) _xbiosynthesis |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 700 | 1 | _aAyeni, Tina A | |
| 700 | 1 | _aRubatt, Jennifer M | |
| 700 | 1 | _aAdams, David J | |
| 700 | 1 | _aGrace, Lisa | |
| 700 | 1 | _aStarr, Mark D | |
| 700 | 1 | _aBarry, William T | |
| 700 | 1 | _aBerchuck, Andrew | |
| 700 | 1 | _aMurphy, Susan K | |
| 700 | 1 | _aSecord, Angeles Alvarez | |
| 773 | 0 |
_tGynecologic oncology _gvol. 121 _gno. 1 _gp. 187-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2010.11.017 _zAvailable from publisher's website |
| 999 |
_c20494088 _d20494088 |
||